Rage Fusion Proteins And Methods Of Use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110124102A1
SERIAL NO

12986602

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

2 domain. Such fusion proteins may provide specific, high affinity binding to RAGE ligands. Also disclosed is the use of the RAGE fusion proteins as therapeutics for RAGE-mediated pathologies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRANSTECH PHARMA LLC4170 MENDENHALL OAKS PARKWAY HIGH POINT NC 27265

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mjalli, Adnan MM Oak Ridge, US 87 1162
Rothlein, Robert Summerfield, US 41 496
Tian, Ye Edward Jamestown, US 36 122
Webster, Jeffrey C Jamestown, US 14 115

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation